Thromboelastogram Complements Conventional Coagulation Tests for Optimal Management of Epidural Catheters in Living Liver Donors

血栓弹力图可作为常规凝血试验的补充,用于活体肝移植供体硬膜外导管的最佳管理

阅读:1

Abstract

BACKGROUND: Reducing postoperative pain and associated morbidity is key for early recovery in healthy, living liver donors. Thoracic epidural analgesia (TEA) is the preferred, time-honoured, and effective pain relief modality, but the safe removal of epidural catheters is often debated, given the deranged conventional coagulation tests (CCTs) like prothrombin time/international normalised ratio (PT/INR) in the early postoperative period in right lobe living donors (RLLDs). AIM: In a prospective observational study conducted in 70 consecutive RLLDs in whom TEA was used for perioperative pain management, we compared the utility and efficacy of CCTs vs. thromboelastogram (TEG) in managing epidural catheter removal. METHODS: CCTs and TEG analysis were performed simultaneously at baseline (before incision) and postoperatively on days 1, 3, and 5. We compared TEG parameters and CCTs till postoperative day (POD) 5 to determine their corroboration and relevance with respect to perioperative coagulation. RESULTS: On POD 3, 53% of RLLDs had a deranged PT/INR, suggesting a hypo-coagulable state, this reduced to 4.3% on POD 5. However, the TEG analysis revealed a brief hypercoagulable state in the immediate postoperative period till POD 5, showing that CCTs alone may be misleading. No TEA-related complications were observed in any of the donors in this study. CONCLUSION: TEG can be used to complement CCTs in guiding optimal management and safe removal of TEA catheters. Furthermore, in the light of these hypercoagulable changes, anti-thrombotic measures including early ambulation, use of pneumatic compression pumps, and/or low-molecular-weight heparin prophylaxis may be considered.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。